Smith Thornton Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,743
Closed -$447K 146
2026
Q1
$447K Buy
3,743
+5
+0.1% +$656 0.23% 87
2025
Q4
$509K Sell
3,738
-32
-0.8% -$4.6K 0.26% 80
2025
Q3
$556K Sell
3,770
-163
-4% -$22.6K 0.29% 75
2025
Q2
$509K Buy
3,933
+62
+2% +$7.51K 0.29% 76
2025
Q1
$462K Buy
3,871
+115
+3% +$14.3K 0.29% 77
2024
Q4
$436K Buy
3,756
+808
+27% +$102K 0.28% 88
2024
Q3
$398K Buy
2,948
+170
+6% +$22.7K 0.26% 94
2024
Q2
$377K Buy
+2,778
New +$378K 0.28% 90

Other funds holding XYL

Smith Thornton Advisors's XYL Position: Q2 2026 in Review

Smith Thornton Advisors sold out of Xylem (XYL) in Q2 2026, closing a stake of 3,743 shares — an estimated $447K sold.

Smith Thornton Advisors first reported a position in XYL in Q2 2024 and held it in 8 quarters. The position peaked at $556K in Q3 2025. 274 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Smith Thornton Advisors reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Smith Thornton Advisors sold 3,743 Xylem shares in Q2 2026, an estimated $447K.
  • Smith Thornton Advisors first reported a position in Xylem in Q2 2024 and held it in 8 quarters.
  • Smith Thornton Advisors's Xylem position peaked at $556K in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Smith Thornton Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.